Catherine Muir

Kate Muir serves as a Contracting Officer at the National Institutes of Health, where she plays a pivotal role in securing advanced scientific infrastructure critical to biomedical discovery. She manages the acquisition of high-precision laboratory instrumentation, specialized biotechnology reagents, computational services, and technical support systems that enable hypothesis-driven research and clinical translation. Her portfolio spans complex, mission-critical procurements requiring deep technical evaluation and compliance with federal acquisition regulations, ensuring NIH’s research ecosystem remains at the forefront of scientific innovation. Muir’s work directly supports the agency’s mandate to advance life sciences through strategic sourcing of cutting-edge tools and services. Muir maintains longstanding relationships with key contractors including Leidos Biomedical Research Inc., Kelly Services, Inc., Fors Marsh Group LLC, PPD Development LP, and The Whiting-Turner Contracting Company. These partnerships reflect a blend of large prime contractors delivering integrated research services, laboratory operations, clinical trial support, and facility construction. Her contracting approach emphasizes performance-based outcomes, rigorous technical validation, and long-term operational reliability, often resulting in multi-year, task-order-driven agreements that align with NIH’s evolving research priorities. Muir’s procurement portfolio exhibits a strong preference for full and open competition, with 100% of her awards issued under no set-aside classifications. While she does not routinely utilize socioeconomic set-asides such as 8(a), HUBZone, or SDVOSB programs, her contracting decisions prioritize technical capability, scientific relevance, and mission alignment over socioeconomic categorization, reflecting NIH’s emphasis on securing the highest-performing solutions for complex biomedical needs. Her primary NAICS focus areas include 334516 for analytical laboratory instrumentation manufacturing, 621511 for medical laboratory services, 811219 for other scientific and technical services, and 541990 for professional scientific consulting. She regularly procures next-generation sequencing platforms, mass spectrometers, bioinformatics software, clinical data management systems, and high-performance computing infrastructure, demonstrating deep expertise in life sciences technology procurement and research-enabling services.